Major Depression Index (MDI)
10-item self-report depression scale derived from ICD-10 and DSM-IV criteria. Can be used as a severity measure (score 0–50) or for diagnosis of depression. Validated in primary care and general practice.
Score interpretation
MDI 0–20 — below threshold for depression diagnosis
→ Psychoeducation; monitor; lifestyle interventions; reassess if symptoms persist or worsen
MDI 21–25 — mild depression
→ Low-intensity interventions (guided self-help, CBT); consider antidepressant if persistent; active monitoring every 2 weeks
MDI 26–30 — moderate depression
→ Antidepressant therapy (SSRI first-line: sertraline 50 mg OD); psychological therapy (CBT); consider psychiatry input; safety assessment
MDI ≥31 — severe depression
→ Urgent psychiatry referral; pharmacotherapy with close monitoring; assess suicide risk (C-SSRS); consider hospitalisation if high risk; combination pharmacotherapy + psychotherapy
Interpretation bands for the MDI. Apply clinical judgement and local guidance.
References
- Bech P et al. The Major Depression Inventory (MDI) as a level of functioning measure. Int J Psychiatry Clin Pract. 2004;8(3):175–182.
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.